Vitamin B12 injections work well in combination with MIC injections.
The most common side effects are gastrointestinal, including nausea, vomiting, diarrhea, and constipationtypically mild to moderate and decreasing over the first 8-12 weeks of treatment
VMR uses time-series analysis, S-curve adoption modeling, regression forecasting, and best/base/worst case scenario modeling, combined with bottom-up and top-down sizing across geographies and segments
Current UK regulatory position includes: Warnings and precautions regarding thyroid C-cell tumours based on animal data, with acknowledgement that human relevance is uncertain Advice regarding pancreatitis risk, with recommendations to discontinue if acute pancreatitis is suspected and not to restart if confirmed No restrictions based on general cancer risk, as human evidence does not support an increased overall malignancy risk Monitoring for gallbladder disease, which has been associated with GLP-1 receptor agonist use The Summary of Product Characteristics (SmPC) for each GLP-1 medicine includes detailed safety information that healthcare professionals should review before prescribing
